The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study
- 28 September 2011
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 59 (3), 556-561
- https://doi.org/10.1111/j.1365-2559.2011.03946.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The evolving classification of soft tissue tumours: an update based on the new WHO classificationHistopathology, 2005
- Protein kinases as targets for anticancer agents: from inhibitors to useful drugsPharmacology & Therapeutics, 2002
- Clinicopathologic Re-Evaluation of 100 Malignant Fibrous Histiocytomas: Prognostic Relevance of SubclassificationJournal of Clinical Oncology, 2001
- Dedifferentiated Liposarcoma Clinicopathologic Analysis of 32 Cases Suggesting a Better Prognostic Subgroup Among Pleomorphic SarcomasThe American Journal of Surgical Pathology, 1994
- Leiomyosarcoma with Prominent Osteoclast-like Giant CellsThe American Journal of Surgical Pathology, 1994
- Pleomorphic Malignant Fibrous HistiocytomaThe American Journal of Surgical Pathology, 1992
- Malignant fibrous histiocytoma?Histopathology, 1987
- Malignant fibrous histiocytoma.An Analysis of 200 CasesCancer, 1978
- Myxoid variant of malignant fibrous histiocytomaCancer, 1977
- Cultural characteristics of malignant histiocytomas and fibrous xanthomasCancer, 1963